Tetrahydroxystilbene-2-O-β-D-glucoside
CAS: 55327-45-2
Ref. TM-T4956
1mg | 74,00 € | ||
5mg | 154,00 € | ||
10mg | 233,00 € | ||
25mg | 388,00 € | ||
50mg | 579,00 € | ||
100mg | 823,00 € | ||
500mg | 1.653,00 € | ||
1ml*10 (DMSO) | 167,00 € |
Información del producto
- tetrahydroxyl diphenylethylene-2-o-gluco, EH-201
- 2,3,5,4'-Tetrahydroxytoluylene-2-Beta-D-Glucoside
- 2,3,5,4′-Tetrahydroxyldiphenylethylene 2-O-β-<span class="text-smallcaps">D</span>-glucoside
- 2,4-Dihydroxy-6-[2-(4-hydroxyphenyl)ethenyl]phenyl β-<span class="text-smallcaps">D</span>-glucopyranoside
- β-<span class="text-smallcaps">D</span>-Glucopyranoside, 2,4-dihydroxy-6-[2-(4-hydroxyphenyl)ethenyl]phenyl
Tetrahydroxystilbene-2-O-β-D-glucoside (EH-201) is a low MW inducer of erythropoietin. Tetrahydroxystilbene-2-O-β-D-glucoside induces expression of erythropoietin, PPAR-γ coactivator 1α (PGC-1α) and haemoglobin in astrocytes and PC12 neuronal-like cells. In vivo, Tetrahydroxystilbene-2-O-β-D-glucoside treatment restores memory impairment, as assessed by the passive avoidance test, in SD, Aβ and KA mouse models. In the hippocampus of mice given Tetrahydroxystilbene-2-O-β-D-glucoside in their diet, levels of erythropoietin, PGC-1α and haemoglobin were increased. Treatment with Tetrahydroxystilbene-2-O-β-D-glucoside might be a therapeutic strategy for memory impairment in neurodegenerative disease, physiological ageing or traumatic brain injury.
Propiedades químicas
Consulta técnica sobre: TM-T4956 Tetrahydroxystilbene-2-O-β-D-glucoside
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.